Portable 12 Lead ECGs Improve Detection and Care Reach
12-lead electrocardiograms are an essential method in providing accurate detections of heart complications in patients. ECGs can observe everything from heart rhythm and irregular heartbeat, identify risk of heart attacks, examine blood flow, and even more, according to WebMd.
The Benefits of a Portable ECG Device
Heart disease, such as Ischemia, is reportedly the number one cause of death in America, killing close to 635,000 people every year. Portable EKG machines, also known as portable ECG machines, were designed to help monitor heart conditions in a more effective and manageable way in order to reduce the number of conditions left untreated and unmonitored. Traditional 12-lead ECG machines are time consuming, requiring connections with twelve separate wired leads to be attached to the patient’s body by a healthcare professional. Due to the size of traditional 12-lead ECG machines, these tests must typically be done in a hospital or office environment.
SHL Telemedicine enters into Agreement with ChristianaCare for use of SmartHeart™ full 12 lead ECG technology
Tel Aviv / Zurich, November 11, 2021 – SHL Telemedicine Ltd. today announced that it has
entered into an agreement with ChristianaCare for the use of SmartHeart™ Platform and
Services. SHL will provide SmartHeart™ 12 Lead ECG unit and technology for the delivery of
ECGs and related services for use in certain clinical and patient care protocols.
SHL Telemedicine enters into Agreement with CVS Pharmacy Inc. for use of SmartHeart™ full 12 lead ECG technology
Tel Aviv / Zurich – 18 October 2021 – SHL Telemedicine Ltd. today announced that it has entered into a Purchase and Service Agreement with CVS Pharmacy Inc, according to which SHL will provide SmartHeartTM 12 lead ECG unit and technology for the delivery of ECGs and related services at select MinuteClinic locations for use in its clinical and patient care protocols.
SHL Telemedicine and Mayo Clinic enter agreement for use of SmartHeart™ technology across different platforms
Tel Aviv / Zurich, 30 August 2021 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN), today announced that it has entered into an Agreement with Mayo Clinic, according to which Mayo Clinic will purchase SHL’s SmartHeartTM 12 Lead ECG unit and technology for the delivery of ECGs and related services, where Mayo Clinic will implement the SmartHeartTM for use in its clinical and patient care protocols.
